NSISBC logo

Novozymes A/SBATS-CHIXE:NSISBC Stock Report

Market Cap DKK 199.1b
Share Price
n/a
1Y7.1%
7D-6.1%
1D-6.1%
Portfolio Value
​
View

Novozymes A/S

BATS-CHIXE:NSISBC Stock Report

Market Cap: DKK 199.1b

Novozymes (NSISBC) Stock Overview

Produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. More details

NSISBC fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance4/6
Financial Health5/6
Dividends3/6

Rewards

Trading at 33% below our estimate of its fair value

Earnings are forecast to grow 13.75% per year

Earnings have grown 5.9% per year over the past 5 years

Risk Analysis

Shares are highly illiquid


NSISBC Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW439,321 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
439,321 investors already sharing narratives
View all narratives

Novozymes A/S Competitors

Price History & Performance

Summary of share price highs, lows and changes for Novozymes
Historical stock prices
Current Share PriceDKK 429.30
52 Week HighDKK 463.35
52 Week LowDKK 339.75
Beta0.63
1 Month Change3.25%
3 Month Change10.47%
1 Year Change7.12%
3 Year Changen/a
5 Year Changen/a
Change since IPO6.00%

Recent News & Updates

Recent updates

Shareholder Returns

NSISBCGB ChemicalsGB Market
7D-6.1%-1.9%-1.8%
1Y7.1%11.4%15.2%

Return vs Industry: NSISBC underperformed the UK Chemicals industry which returned 12% over the past year.

Return vs Market: NSISBC underperformed the UK Market which returned 14.4% over the past year.

Price Volatility

Is NSISBC's price volatile compared to industry and market?
NSISBC volatility
NSISBC Average Weekly Movementn/a
Chemicals Industry Average Movement6.4%
Market Average Movement4.9%
10% most volatile stocks in GB Market10.3%
10% least volatile stocks in GB Market2.5%

Stable Share Price: NSISBC's share price has been volatile over the past 3 months compared to the UK market.

Volatility Over Time: Insufficient data to determine NSISBC's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a11,098Ester Baigetwww.novonesis.com

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The company also offers bioenergy solutions including biodiesel; biogas from agricultural and industrial residues and food waste; biomass; carbon capture; ethanol for liquefaction, saccharification, fermentation, and fiber conversion; and renewable diesel.

Novozymes A/S Fundamentals Summary

How do Novozymes's earnings and revenue compare to its market cap?
NSISBC fundamental statistics
Market capDKK 199.09b
Earnings (TTM)DKK 4.72b
Revenue (TTM)DKK 32.12b
42.2x
P/E Ratio
6.2x
P/S Ratio

Is NSISBC overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NSISBC income statement (TTM)
Revenue€4.30b
Cost of Revenue€1.87b
Gross Profit€2.42b
Other Expenses€1.79b
Earnings€631.60m

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

Nov 05, 2026

Earnings per share (EPS)1.36
Gross Margin56.39%
Net Profit Margin14.70%
Debt/Equity Ratio25.8%

How did NSISBC perform over the long term?

See historical performance and comparison

Dividends

1.5%
Current Dividend Yield
65%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/11 15:39
End of Day Share Price 2026/09/11 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Novozymes A/S is covered by 28 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Cezara LozneanuBarclays
Alexander SloaneBarclays
Sebastian SatzBarclays